Search

Search Results

• PO:16:234 | Differential efficacy of induction treatments for lupus nephritis at onset and relapses: an observational study Giuseppe Alvise Ramirez^1|2, Gabriele D Gallina¹, Chiara Calabrese^1|2, Serena Nannipieri^1|2, Marta Calatroni^3|4, Francesco Reggiani^3|4, Giovanni Benanti¹, Enrica Paola Bozzolo¹, Raffaele Ceniccola², Luca Moroni^1|2, Marco Matucci-Cerinic^1|2, Gabriella Moroni^3|4, Lorenzo Dagna^1|2 | ¹IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases Milan, Italy; ²Vita- Salute San Raffaele University Milan, Italy; ³IRCCS Humanitas Research Hospital, Nephrology and Dialysis Division Rozzano, Milan, Italy; ⁴Humanitas University, Department of Biomedical Sciences Rozzano, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2334

  28

• PO:15:215 | Evaluating the Prognostic Value of Modified NIH Indices and Total Renal Chronicity Score in Lupus Nephritis: a single center retrospective analysis Alessandra Ida Celia¹, Andrea Ascione², Bruna Cerebelli², Martina Leopizzi², Cristiano Alessandri¹, Francesca Romana Spinelli¹, Fabrizio Conti¹ | ¹Reumaologia, Scienze Cliniche internistiche, anestesiologiche e cardiovascolari, Università La Sapienza di Roma, Italy; ²Anatomia patologica, Dipartimento di Scienze biotecnologiche medico-chirurgiche, Università La Sapienza di Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2328

  10

• PO:03:034 | Inhibition of Radiographic Progression with Bimekizumab Treatment Observed in bDMARD-Naïve Patients with Active Psoriatic Arthritis at 2 Years: Results from a Phase 3 Study and its Open-Label Extension Laura C Coates¹, M Elaine Husni², Mitsumasa Kishimoto³, Proton Rahman⁴, Philipp Sewerin⁵, Enrique R Soriano⁶, Barbara Ink⁷, Rajan Bajracharya⁷, Jason Coarse⁸, Philip J Mease⁹, Emanuela Mazzola¹⁰, Peter Nash¹¹ | ¹NDORMS, University of Oxford and Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust Oxford, United Kingdom; ²Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Cleveland, USA; ³Department of Nephrology and Rheumatology, Kyorin University School of Medicine Tokyo, Japan; ⁴Division of Rheumatology, Craig L. Dobbin Genetics Research Centre, Memorial University of Newfoundland St. Johns, Canada; ⁵Rheumazentrum Ruhrgebiet, University Hospital of the Ruhr University Bochum Herne Germany; ⁶Hospital Italiano de Buenos Aires and University Institute Hospital Italiano de Buenos Aires Buenos Aires, Argentina; ⁷UCB Slough, United Kingdom; ⁸UCB Morrisville, USA; ⁹Department of Rheumatology, Providence-Swedish Medical Center and University of Washington Seattle, USA; ¹⁰UCB Milan, Italy; ¹¹School of Medicine, Griffith University, Brisbane, Australia

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2290

  39

• PO:19:286 | Genetic testing reveals an unexpected case of mevalonate kinase deficiency in a 37-year-old patient with AA renal amyloidosis and good response to colchicine Francesca Crisafulli¹, Paolo Airò², Federica Mescia³, Gianmarco Lugli³, Gianfranco Savoldi⁴, Claudia Izzi^3|5, Federico Alberici³, Marco Cattalini⁶, Franco Franceschini¹, Micol Frassi². | ¹Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy; ²Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy; ³U.O Nefrologia, ASST Spedali Civili di Brescia e Università degli Studi di Brescia, Brescia, Italy; ⁴Medical genetics Laboratory, Laboratory Department ASST Spedali Civili di Brescia, Brescia, Italy; ⁵Struttura Complessa di Genetica Clinica, ASST Spedali Civili di Brescia, Brescia, Italy; ⁶Pediatrics Clinic, University of Brescia and ASST Spedali Civili of Brescia, Brescia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2049

  142